scholarly journals Complications after endoprosthetic joint replacement in patients receiving genetically engineered biological agents

2012 ◽  
Vol 0 (3) ◽  
pp. 43
Author(s):  
Elena Yuryevna Pogozheva ◽  
V N Amirdzhanova ◽  
S A Makarov ◽  
E L Nasonov
2018 ◽  
Vol 97 (3) ◽  
pp. 52-61
Author(s):  
E.S. Zholobova ◽  
◽  
A.K. Ignatova ◽  
N.G. Seylanova ◽  
A.P. Golubeva ◽  
...  

2014 ◽  
Vol 13 (1) ◽  
pp. 33-50
Author(s):  
A.A. Baranov ◽  
◽  
E.I. Alexeeva ◽  
S.I. Valieva ◽  
T.M. Bzarova ◽  
...  

2012 ◽  
Vol 0 (4) ◽  
pp. 91 ◽  
Author(s):  
V V Neroyev ◽  
L A Katargina ◽  
E V Denisova ◽  
A V Starikova ◽  
N V Lyubimova

Author(s):  
William J.S. Aston ◽  
Gordon Blunn ◽  
Timothy W.R. Briggs

♦ The aims of the bone tumour surgeon are to improve survival and maintain optimal function of the patient; this can be achieved by amputation or limb salvage♦ Limb salvage provides no greater risk to the survival of the patient than with amputation♦ Reconstruction after removal of the tumour is commonly achieved by using endoprosthetic replacements, autografts, or massive allografts♦ Complications of limb salvage include infection and difficulties associated with soft tissue reattachment and coverage of the bone replacement.


2011 ◽  
Vol 0 (5) ◽  
pp. 46
Author(s):  
N. A. Savenkova ◽  
V. N. Amirdzhanova ◽  
S. A. Makarov ◽  
A. L. Logunov ◽  
M. A. Makarov ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document